Understanding how molecules interact to form large-scale hierarchical structures on
surfaces holds promise for building designer nanoscale constructs with defined chemical …

Alzheimer's disease (AD) is a neurodegenerative disorder of the elderly. As the prevalence
of AD rises in the 21st century, there is an urgent need for the development of effective …

The pathogenesis underlining many neurodegenerative diseases remains incompletely
understood. The lack of effective biomarkers and disease preventative medicine demands …

Brain disorders such as brain tumors and neurodegenerative diseases (NDs) are
accompanied by chemical alterations in the tissues. Early diagnosis of these diseases will …

Throughout biology, amyloids are key structures in both functional proteins and the end
product of pathologic protein misfolding. Amyloids might also represent an early precursor in …

Cu bound to amyloid‐β (Aβ) peptides can act as a catalyst for the formation of reactive
oxygen species (ROS), leading to neuropathologic degradation associated with Alzheimer's …

Metals are commonly found in the environment, household, and workplaces in various
forms, and a significant segment of the population is routinely exposed to the trace amount …

Altered regulation of copper (Cu) homeostasis may contribute to the development of many
pathologies, such as metabolic, cardiovascular, neurodegenerative and cancerous …

In Alzheimer's disease (AD), the most common cause of dementia, patients generally forget
to take pills or skip medication due to side effects, affecting the treatment efficacy. In this …

Alzheimer's disease (AD) is a neurological condition currently with 47 million people
suffering from it globally. AD might have many reasons such as genetic issues …